FibroGen Story Overview

FGEN -- USA Stock  

USD 39.55  0.56  1.44%

Macroaxis does not monitor all media channels or aggregates social signals for FibroGen. But even though we do not provide professional-grade financial sentiment analysis on FibroGen, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for FibroGen. Additionally see FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance.
Insider Selling FibroGen, Inc Director Sells 567000.00 in Stock
EcoR1 Capital LLC lifted its holdings in FibroGen by 3,674.1 percent in the second quarter. EcoR1 Capital LLC now owns 1,585,457 shares of the biopharmaceutical company stock valued at 51,210,000 after acquiring an additional 1,543,448 shares during the ... Traders Brace for Comeback of Volatility FibroGen, Inc. , Frontline Ltd ... - Post Analyst

Read More...   

Story Momentum

This media report from www.thelincolnianonline.com distributed on December 7, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 2.54% . The overall trading delta when the story was published against the current closing price is 12.60% .

Similar stores for FibroGen

Equity Review Investors Keen on FibroGen, Inc as it Makes Waves With Moves - The Coin Guildnews
Equity Review Investors Keen on FibroGen, Inc as it Makes Waves With Moves The Coin GuildFibroGen Inc CEO Sells 1,227,900.00 in Stock Fairfield CurrentFibroGen, Inc. Suggested Portfolio Weight Should be No More Than 0.0182 According to Quant Stock News OracleFibroGen Inc Stake Lessened by Rhumbline Advisers PressOracleFibrogen Inc Sellers Reduced By 13.64 percent Their Shorts As Of Dec 16, 2018 Z TribuneView full coverage on Google News
Dupont Capital Management Corp Purchases New Stake in FibroGen Inc - Fairfield Currentnews
Dupont Capital Management Corp Purchases New Stake in FibroGen Inc Fairfield CurrentDupont Capital Management Corp purchased a new stake in shares of FibroGen Inc in the third quarter, according to its most recent filing with ...
over a week ago at www.macroaxis.com 
Acquisition by Ho Maykin of 3008 shares of FibroGen subject to Rule 16b-3
Macroaxis News
Filed transaction by Fibrogen Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over a week ago at http://stockmarketfloor.com 
Americold Realty Trust moved of 0.49 percent and FibroGen, Inc. closed at 43.93, Performance Based Analysis of...
news
Americold Realty Trust moved of 0.49 percent and FibroGen, Inc. closed at 43.93, Performance Based Analysis of Stock Stock Market FloorAmericold Realty Trust s closed at 26.93 with move of 0.49 percent on Monday. Investors of this company earned a return of 1.70 percent on the assets it owns in ...
over two weeks ago at http://www.baseballdailydigest.com 
FibroGen Inc Holdings Reduced by Millennium Management LLC - Baseball Daily News
news
FibroGen Inc Holdings Reduced by Millennium Management LLC Baseball Daily NewsMillennium Management LLC trimmed its stake in shares of FibroGen Inc by 87.6 percent during the second quarter, according to its most recent ...
over two weeks ago at http://www.thecoinguild.com 
Market News Investors Keen on FibroGen, Inc as it Makes Waves With Moves - The Coin Guild
news
Market News Investors Keen on FibroGen, Inc as it Makes Waves With Moves The Coin GuildMajor market players are buzzing over FibroGen, Inc as their share price hit 40.32 at the end of the most recent trading session.
over three weeks ago at http://thestockvoice.com 
Wall Street Target Update on Shares of FibroGen, Inc - Stock Voice
news
Wall Street Target Update on Shares of FibroGen, Inc Stock VoiceMonitoring some price target data, we have noticed that shares of FibroGen, Inc currently have an average target of 78. This number is the.
over three weeks ago at http://www.mareainformativa.com 
FibroGen Hits New 1-Year Low Following Insider Selling
news
Marea Informative Full coverage
over a month ago at www.macroaxis.com 
Exercise or conversion by Kalevi Kurkijarvi of 4000 shares of FibroGen subject to Rule 16b-3
Macroaxis News
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at http://pressoracle.com 
Insider Selling FibroGen Inc Director Sells 4000 Shares of Stock
news
PressOracleFibroGen Inc Shares Bought by Moody Aldrich Partners LLC Baseball Daily NewsFull coverage
over a month ago at www.macroaxis.com 
Exercise or conversion by Thomas Neff of 10319 shares of FibroGen subject to Rule 16b-3
Macroaxis News
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three months ago at http://www.fairfieldcurrent.com 
FibroGen Inc SVP Sells 57980.85 in Stock
news
Fairfield CurrentFull coverage
over three months ago at www.macroaxis.com 
Sale by Jorma Routti of 3700 shares of FibroGen
Macroaxis News
Filed transaction by Fibrogen Inc director. General open market or private sale of non-derivative or derivative security

Price to Sales

Price to Sales Comparative Analysis

FibroGen is currently under evaluation in price to sales category among related companies. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Additionally see FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com